Hildred
Overview
Hildred is a New York City-based private equity investment firm focused on control-oriented investments in lower middle-market companies across the healthcare industry. The firm's investment focus includes commercial stage pharmaceutical and OTC products, care delivery services, medical devices, life science tools and diagnostics, outsourced pharmaceutical and clinical services, and healthcare IT. Hildred partners with management teams to drive strategic growth and create value.
Portfolio Companies
6
Website
hildred.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HealthCare.com | Dec 2021 | Series C | Lead |
| Tebra | Dec 2025 | Private Equity | Lead |
| OrangeTwist | Dec 2025 | Strategic | Co-investor |
| binx health | Apr 2024 | Series F | Lead |
For institutional investors. Book with your work email.
Key People
Kevin Regan
Principal
Adrianne Shapira
Private Equity Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Hildred based?
Hildred is headquartered in New York City, New York, United States.
When was Hildred founded?
Founding year information for Hildred is not publicly available.
How many portfolio companies does Hildred have?
Hildred has 6 portfolio companies in Caplight's dataset.
What are some companies in Hildred's portfolio?
Portfolio companies visible on Caplight include HealthCare.com, Tebra, OrangeTwist, binx health.
What was Hildred's most recent investment shown here?
Hildred's most recent investment in this portfolio sample was in OrangeTwist in 2025.
What sectors does Hildred focus on?
Hildred focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences.
What company stages does Hildred focus on?
Hildred typically invests at the Late stage.
What is Hildred's AUM?
Hildred's assets under management are estimated between $2.7B and $3.0B.